International Stem Cell
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$1.32M
-0.8
0.06
$3.67M
33
International Stem Cell Corp. operates as a research and development company for the therapeutic market. The company is headquartered in San Diego, California and currently employs 33 full-time employees. The company went IPO on 2006-09-25. The firm is primarily a research and development company for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The firm's products are based on human cell culture and types of pluripotent stem cells and hpSCs. The firm's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC), which develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.
International Stem Cell Corp. operates as a research and development company for the therapeutic market. The company is headquartered in San Diego, California and currently employs 33 full-time employees. The company went IPO on 2006-09-25. The firm is primarily a research and development company for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The firm's products are based on human cell culture and types of pluripotent stem cells and hpSCs. The firm's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC), which develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.
Recently from Cashu
ISCO International licenses autonomous Open RAN RF-shield software for mission‑critical 5G networks
Autonomous RF shield offered to Open RAN operators ISCO International is licensing its patented Interference Management and Cancellation (IMC) software to operators and equipment vendors for use in mi…
International Stem Cell (ISCO) Licenses Open RAN IMC to Protect Mission-Critical 5G
International Stem Cell advances licensed software to protect 5G for critical services International Stem Cell Corp (ISCO) is offering licensing for its patented Interference Management and Cancellati…
ISCO Spirits Partners with Southern Glazer's for Expanded Distribution of Unique Beverages
ISCO Spirits Expands Reach with New Distribution Agreement ISCO Spirits, renowned for its sustainably sourced and handcrafted spirits, announces a pivotal distribution agreement with Southern Glazer's…
ISCO Spirits Partners with Southern Glazer's for Expanded Distribution and Innovative Product Launches
ISCO Spirits Expands Reach with Southern Glazer's Distribution Agreement ISCO Spirits, a company recognized for its sustainably sourced and handcrafted spirits, announces a new distribution agreement…